Switch to:
GlaxoSmithKline PLC (NYSE:GSK)
Cash Flow for Capital Expenditures
$-2,820 Mil (TTM As of Jun. 2014)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

GlaxoSmithKline PLC's cash flow for capital expenditures for the three months ended in Jun. 2014 was $-672 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2014 was $-2,820 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

GlaxoSmithKline PLC Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Jun. 2014 was -739.130434783 (Sep. 2013 ) + -823.723228995 (Dec. 2013 ) + -584.58961474 (Mar. 2014 ) + -672.354948805 (Jun. 2014 ) = $-2,820 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

GlaxoSmithKline PLC Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Cash Flow_CPEX -1,960-2,090-3,117-4,223-2,990-3,026-2,579-2,062-2,428-2,802

GlaxoSmithKline PLC Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
Cash Flow_CPEX -408-560-616-1,569-485-645-739-824-585-672
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK